论文部分内容阅读
目的观察曲美他嗪治疗缺血性心脏病心力衰竭的效果。方法观察对象为2015年12月—2016年12月本院缺血性心脏病心力衰竭患者总共69例,经掷硬币法分两组。一组有33例,采取常规治疗,设对照组。另一组有36例,应用曲美他嗪,设观察组。治疗后组间对比疗效。结果治疗后观察组LVEDD较低,LVEF较高;治疗总有效率高,经统计学处理,P<0.05,有显著差异,有统计学意义。结论缺血性心脏病心力衰竭治疗采用曲美他嗪,疗效确切,临床可推广使用。
Objective To observe the effect of trimetazidine on heart failure in patients with ischemic heart disease. Methods A total of 69 patients with heart failure from ischemic heart disease in our hospital from December 2015 to December 2016 were enrolled in this study. The patients were divided into two groups by coin tossing. A group of 33 cases, to take conventional treatment, set the control group. Another group of 36 cases, application of trimetazidine, observation group. Comparison between groups after treatment efficacy. Results After treatment, the LVEDD was lower and the LVEF was higher in the observation group. The total effective rate was high. After statistical treatment, the difference was statistically significant (P <0.05). Conclusion The treatment of ischemic heart disease with trimetazidine heart failure, the exact effect of clinical promotion.